27 Oct Beta Testing
An article this week on StatNews.com, a sister site of BostonGlobe.com, reported on a California startup’s plan to broadly market the medication propranolol as a quality-of-life aid, including to reduce nervousness associated with public speaking.
Companies looking to innovate and disrupt will continue to explore new solutions to old problems, and vice versa. But this particular idea causes me concern as a speech professional. (more…)